Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myriad Genetics (MYGN) Income from Non-Controlling Interests (2017 - 2020)

Myriad Genetics has reported Income from Non-Controlling Interests over the past 4 years, most recently at -$100000.0 for Q2 2020.

  • Quarterly Income from Non-Controlling Interests changed 0.0% to -$100000.0 in Q2 2020 from the year-ago period, while the trailing twelve-month figure was -$100000.0 through Mar 2021, changed 0.0% year-over-year, with the annual reading at -$100000.0 for FY2020, N/A changed from the prior year.
  • Income from Non-Controlling Interests was -$100000.0 for Q2 2020 at Myriad Genetics, roughly flat from -$100000.0 in the prior quarter.
  • Over five years, Income from Non-Controlling Interests peaked at -$100000.0 in Q3 2017 and troughed at -$200000.0 in Q2 2017.
  • The 4-year median for Income from Non-Controlling Interests is -$100000.0 (2017), against an average of -$116666.7.
  • The largest YoY upside for Income from Non-Controlling Interests was 0.0% in 2018 against a maximum downside of 0.0% in 2018.
  • A 4-year view of Income from Non-Controlling Interests shows it stood at -$100000.0 in 2017, then changed by 0.0% to -$100000.0 in 2018, then changed by 0.0% to -$100000.0 in 2019, then changed by 0.0% to -$100000.0 in 2020.
  • Per Business Quant, the three most recent readings for MYGN's Income from Non-Controlling Interests are -$100000.0 (Q2 2020), -$100000.0 (Q2 2019), and -$100000.0 (Q3 2018).